Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

bluebird bio, Inc. - Common Stock (NQ:BLUE)

4.970 UNCHANGED
Last Price Updated: 4:00 PM EDT, May 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about bluebird bio, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
News headline image
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck ↗
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,... 
Via Benzinga
News headline image
Is bluebird bio a Buy for Summer 2021? ↗
With the stock down 54% over the past year, will investors be catching a falling knife if they buy now? 
Via The Motley Fool
News headline image
Bluebird bio's Neurological Disorder Gene Therapy Wins CHMP Backing for Approval ↗
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorizations for Bluebird bio Inc’s... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers Enveric Biosciences (NASDAQ:ENVB)... 
Via Benzinga
News headline image
What Investors Need to Know About This $419,500 CAR-T Cancer Treatment ↗
Abecma is on the market. 
Via The Motley Fool
News headline image
Will Vertex's Sickle Cell Gambit Sink bluebird bio's Stock? ↗
The competition is starting to heat up, but bluebird is far from finished. 
Via The Motley Fool
News headline image
Is bluebird bio a Bad News Buy? ↗
The biotech has had a rough couple of years. 
Via The Motley Fool
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.